Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
29.06
+0.58 (2.04%)
Mar 4, 2026, 12:34 PM EST - Market open

Agios Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,7031,5911,8781,2461,5461,786
Market Cap Growth
-10.54%-15.29%50.75%-19.39%-13.46%-40.52%
Enterprise Value
544.47776.751,041540.96848.05863.04
Last Close Price
29.0627.2232.8622.2728.0832.87
PE Ratio
--3.822.82-3.52-6.641.24
PS Ratio
30.8929.4551.4646.45108.53-
PB Ratio
1.401.331.221.541.401.38
P/TBV Ratio
1.411.321.231.531.401.54
P/FCF Ratio
--4.22-4.80-4.19-4.92-4.38
P/OCF Ratio
--4.27-4.82-4.21-4.99-4.38
EV/Sales Ratio
10.0814.3828.5320.1759.55-
EV/EBITDA Ratio
--1.66-2.48-1.41-2.23-2.34
EV/EBIT Ratio
--1.65-2.45-1.38-2.18-2.28
EV/FCF Ratio
--2.06-2.66-1.82-2.70-2.12
Debt / Equity Ratio
0.030.030.040.090.080.08
Debt / EBITDA Ratio
-0.09-0.09-0.14-0.19-0.22-0.26
Debt / FCF Ratio
-0.11-0.11-0.15-0.24-0.27-0.24
Net Debt / Equity Ratio
-0.68-0.68-0.54-0.87-0.63-0.71
Net Debt / EBITDA Ratio
1.741.741.991.831.832.50
Net Debt / FCF Ratio
2.162.162.142.372.222.27
Asset Turnover
0.040.040.030.020.010
Inventory Turnover
0.210.210.180.210.40-
Quick Ratio
10.5210.5211.0611.4712.5417.12
Current Ratio
11.4611.4611.9012.2713.3017.79
Return on Equity (ROE)
-30.20%-30.20%57.29%-36.83%-19.38%189.74%
Return on Assets (ROA)
-31.82%-31.82%-30.73%-35.98%-29.07%-33.04%
Return on Invested Capital (ROIC)
-86.82%-86.82%-98.25%-152.37%-100.31%-126.02%
Return on Capital Employed (ROCE)
-33.76%-33.76%-34.74%-38.28%-30.47%-35.42%
Earnings Yield
-24.74%-26.16%35.42%-28.42%-15.06%80.77%
FCF Yield
-22.61%-23.71%-20.85%-23.84%-20.34%-22.81%
Buyback Yield / Dilution
-0.55%-0.55%-0.77%-0.44%-0.17%42.84%
Updated Feb 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q